Coloplast A/S (OTCMKTS:CLPBY) Sets New 52-Week Low – What’s Next?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $5.83 and last traded at $5.8350, with a volume of 1228 shares. The stock had previously closed at $5.92.

Analyst Ratings Changes

Several research firms have commented on CLPBY. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. The Goldman Sachs Group lowered shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

Coloplast A/S Stock Performance

The stock has a market cap of $12.96 billion, a PE ratio of 41.07, a price-to-earnings-growth ratio of 1.83 and a beta of 0.18. The stock has a fifty day moving average of $6.31 and a 200-day moving average of $7.39. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.09 by $0.01. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%.The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.11 billion. On average, equities analysts forecast that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.